Alpha Tau Medical Income Statement (2020-2025) | DRTS

Income Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Cost of Revenue (Quarter)
0.17M0.09M0.10M0.13M0.21M0.12M0.25M0.40M0.40M0.52M0.55M0.45M0.53M0.60M0.53M0.69M0.46M0.46M0.49M0.45M
Operating items
Research & Development (Quarter)
2.19M3.00M3.03M3.23M5.24M5.45M4.83M5.38M6.31M5.96M6.67M7.49M6.45M6.87M6.17M7.53M7.17M7.01M8.31M9.58M
Selling, General & Administrative (Quarter)
0.38M0.39M0.50M0.59M3.34M2.44M2.28M2.21M1.94M1.69M1.70M2.00M1.44M1.59M1.59M2.05M1.68M2.18M1.93M2.57M
Operating Expenses (Quarter)
2.57M3.39M3.53M3.82M8.57M7.89M7.11M7.59M8.24M7.65M8.37M9.49M7.89M8.45M7.76M9.59M8.85M9.19M10.24M12.15M
Operating Income (Quarter)
2.73M3.48M3.63M3.94M8.78M8.01M7.36M7.99M8.64M8.17M8.93M9.94M8.42M9.05M8.29M10.27M9.31M9.65M10.73M12.60M
EBIT (Quarter)
2.73M3.48M3.63M3.94M8.78M8.01M7.36M7.99M8.64M8.17M8.93M9.94M8.42M9.05M8.29M10.27M9.31M9.65M10.73M12.60M
Non-operating items
Interest & Investment Income (Quarter)
-0.48M-0.44M-1.69M-0.72M0.40M
Other Non Operating Income (Quarter)
10.82M8.14M
Non Operating Income (Quarter)
3.49M1.17M-0.15M16.96M-6.02M-4.74M-4.59M-0.48M0.50M-3.97M-2.59M-1.37M-0.80M-0.43M
Net income details
EBT (Quarter)
11.70M6.97M4.80M3.79M25.74M1.99M2.61M3.39M8.17M8.67M4.95M7.36M7.98M7.37M6.92M9.47M8.59M10.05M11.69M12.17M
Tax Provisions (Quarter)
0.01M0.01M-0.01M-0.01M0.00M0.01M0.01M0.00M0.02M0.03M-0.04M0.01M0.00M0.00M0.00M0.10M0.07M-0.01M-0.04M
Profit After Tax (Quarter)
-11.71M6.98M4.80M3.78M25.74M2.00M2.62M3.40M8.19M8.69M4.91M7.37M7.98M7.37M6.92M9.48M8.69M10.11M11.69M12.14M
Income from Continuing Operations (Quarter)
11.69M6.95M4.81M3.81M25.74M1.99M2.60M3.39M8.14M8.64M4.99M7.35M7.98M7.36M6.92M9.47M8.49M9.98M11.70M12.21M
Consolidated Net Income (Quarter)
11.69M6.95M4.81M3.81M25.74M1.99M2.60M3.39M8.14M8.64M4.99M7.35M7.98M7.36M6.92M9.47M8.49M9.98M11.70M12.21M
Income towards Parent Company (Quarter)
11.69M6.95M4.81M3.81M25.74M1.99M2.60M3.39M8.14M8.64M4.99M7.35M7.98M7.36M6.92M9.47M8.49M9.98M11.70M12.21M
Net Income towards Common Stockholders (Quarter)
11.69M6.95M4.81M3.81M25.74M1.99M2.60M3.39M8.14M8.64M4.99M7.35M7.98M7.36M6.92M9.47M8.49M9.98M11.70M12.21M
Additional items
EPS (Basic) (Quarter)
0.04M0.02M0.01M0.090.05M0.00M0.01M0.050.07M0.04M0.02M0.110.07M0.03M0.02M0.140.07M11.790.03M0.15
EPS (Weighted Average and Diluted) (Quarter)
0.090.050.110.03M0.140.04M0.15
Shares Outstanding (Weighted Average) (Quarter)
290.00460.00580.0040.53M540.00480.00490.0063.53M120.00240.00310.0069.38M110.00220.00320.0069.93M120.000.85M390.0080.58M
Shares Outstanding (Diluted Average) (Quarter)
40.53M63.53M69.38M220.0069.93M250.0080.58M
EBITDA (Quarter)
11.71M6.98M4.80M3.78M25.74M2.00M2.62M3.40M8.19M8.69M4.91M7.37M7.98M7.37M6.92M9.48M8.69M10.11M11.69M12.14M
Interest Expenses (Quarter)
8.96M0.04M10.91M
Tax Rate (Quarter)
0.09%0.22%-0.10%-0.37%0.01%0.30%0.34%0.09%0.26%0.30%-0.79%0.11%0.01%0.04%0.02%1.15%0.65%-0.07%-0.29%